Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Two abstracts document antimycobacterial activity of new benzoxazinorifamycin

April 19, 2000

Artemisinin analogue synthesized and evaluated in vitro for antimalarial activity

April 19, 2000

Polyethers from Fujisawa exert broad-spectrum antiinfective activity

April 19, 2000

In vitro and in vivo activity of novel 1beta-methylcarbapenem

April 19, 2000

UCLA describes novel antimicrobial peptides

April 18, 2000

Novel antimalarial drug candidate presented at scientific meeting

April 17, 2000

Pola focuses on development of antifungal agents

April 17, 2000

Sitafloxacin goes head-to-head with imipenem/cilastatin in phase II comparative trial

April 14, 2000

Tamiflu launched in Latin America

April 13, 2000

Phase III results in for pleconaril: ViroPharma reaffirms commitment to novel antiviral drug

April 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...